Positively Sharing

Clinical Trial of New HIV Vaccine Suggests That 97% Of Participants That Got It Developed the Desired Antibodies

Reading Time: < 1 minute

First human trials of a new HIV vaccine have been conducted by Scripps Research and are showing great promise. Read More

Exit mobile version